Taiwan Liposome Profit Margin 2018-2020 | TLC

Current and historical gross margin, operating margin and net profit margin for Taiwan Liposome (TLC) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Taiwan Liposome net profit margin as of March 31, 2020 is -1321.75%.
Taiwan Liposome Annual Profit Margins
Taiwan Liposome Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.225B $0.007B
Taiwan Liposome Company Ltd. is a specialty pharmaceutical company. It focuses on development and commercialization of novel nanomedicines designed to target unmet medical need in pain management, ophthalmology and oncology. The company's product pipeline consists of TLC599, TLC590, TLC399 and TLC178 which are in clinical stage. Taiwan Liposome Company Ltd. is headquartered in Taipei City, Taiwan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.086B 36.94
Takeda Pharmaceutical (TAK) Japan $56.529B 9.91
Astellas Pharma (ALPMY) Japan $31.017B 15.72
Eisai (ESALY) Japan $23.530B 20.40
UCB SA (UCBJF) Belgium $22.485B 0.00
Merck (MKGAF) Germany $14.895B 19.53
Grifols, S.A (GRFS) Spain $12.541B 15.59
Catalent (CTLT) United States $11.354B 43.89
Neurocrine Biosciences (NBIX) United States $11.330B 52.36
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 19.78
Ionis Pharmaceuticals (IONS) United States $8.214B 43.67
IPSEN SA ADR (IPSEY) France $6.994B 0.00
Orion OYJ (ORINY) Finland $6.766B 30.32
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.107B 9.77
United Therapeutics (UTHR) United States $5.325B 10.09
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.396B 479.89
Nektar Therapeutics (NKTR) United States $4.122B 0.00
Evotec AG (EVTCY) Germany $4.062B 109.59
Hypermarcas (HYPMY) Brazil $3.800B 11.56
FibroGen (FGEN) United States $3.611B 0.00
ChemoCentryx (CCXI) United States $3.559B 0.00
PTC Therapeutics (PTCT) United States $3.322B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.544B 10.45
Pacira BioSciences (PCRX) United States $2.210B 45.23
Sage Therapeutics (SAGE) United States $2.159B 0.00
Cronos Group (CRON) Canada $2.097B 60.10
Corcept Therapeutics (CORT) United States $1.928B 19.11
Indivior (INVVY) United States $1.904B 23.64
Xencor (XNCR) United States $1.846B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.830B 0.00
Akebia Therapeutics (AKBA) United States $1.769B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.645B 12.59
USANA Health Sciences (USNA) United States $1.543B 15.82
Zogenix (ZGNX) United States $1.495B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.425B 15.35
Esperion Therapeutics (ESPR) United States $1.417B 0.00
Portola Pharmaceuticals (PTLA) United States $1.412B 0.00
Karyopharm Therapeutics (KPTI) United States $1.385B 0.00
Heron Therapeutics (HRTX) United States $1.333B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.324B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.250B 0.00
Translate Bio (TBIO) United States $1.127B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.004B 44.83
Tilray (TLRY) Canada $0.888B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.841B 0.00
ImmunoGen (IMGN) United States $0.802B 0.00
Endo (ENDP) Ireland $0.788B 1.22
Aerie Pharmaceuticals (AERI) United States $0.686B 0.00
Trillium Therapeutics (TRIL) Canada $0.675B 0.00
VAXART, INC (VXRT) United States $0.657B 0.00
Radius Health (RDUS) United States $0.632B 0.00
Molecular Templates (MTEM) United States $0.631B 0.00
Ardelyx (ARDX) United States $0.615B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.608B 0.00
Collegium Pharmaceutical (COLL) United States $0.601B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.575B 0.00
Flexion Therapeutics (FLXN) United States $0.507B 0.00
Siga Technologies (SIGA) United States $0.479B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.478B 11.55
Innate Pharma SA (IPHYF) France $0.476B 0.00
DURECT (DRRX) United States $0.455B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.450B 17.56
Ocular Therapeutix (OCUL) United States $0.445B 0.00
MEI Pharma (MEIP) United States $0.438B 0.00
Harpoon Therapeutics (HARP) United States $0.415B 0.00
Organogenesis Holdings (ORGO) United States $0.407B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.394B 0.00
Calithera Biosciences (CALA) United States $0.372B 0.00
OptiNose (OPTN) United States $0.342B 0.00
TherapeuticsMD (TXMD) United States $0.340B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.308B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.303B 0.00
Concert Pharmaceuticals (CNCE) United States $0.295B 0.00
Lannett Co Inc (LCI) United States $0.293B 6.42
PROFOUND MEDICL (PROF) Canada $0.272B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.262B 0.00
CASI Pharmaceuticals (CASI) United States $0.252B 0.00
Redhill Biopharma (RDHL) Israel $0.236B 0.00
Jounce Therapeutics (JNCE) United States $0.235B 5.61
Rafael Holdings (RFL) United States $0.227B 0.00
KalVista Pharmaceuticals (KALV) United States $0.216B 0.00
IMV INC (IMV) Canada $0.190B 0.00
Nivalis Therapeutics (ALPN) United States $0.180B 0.00
Nature's Sunshine Products (NATR) United States $0.175B 23.10
Altimmune (ALT) United States $0.166B 0.00
Aquestive Therapeutics (AQST) United States $0.163B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.153B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.116B 0.00
Champions Oncology (CSBR) United States $0.114B 0.00
Otonomy (OTIC) United States $0.112B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.110B 0.00
Recro Pharma (REPH) United States $0.107B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.106B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.100B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.098B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.095B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.095B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.095B 0.00
Sundial Growers (SNDL) Canada $0.086B 0.00
CTI BioPharma (CTIC) United States $0.085B 0.00
Hemispherx BioPharma (AIM) United States $0.081B 0.00
MediWound (MDWD) Israel $0.081B 0.00
SCYNEXIS (SCYX) United States $0.074B 0.00
Biomerica (BMRA) United States $0.072B 0.00
Heat Biologics (HTBX) United States $0.071B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.070B 0.00
Aclaris Therapeutics (ACRS) United States $0.068B 0.00
CV Sciences (CVSI) United States $0.062B 0.00
Lipocine (LPCN) United States $0.060B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.052B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.051B 30.27
Addex Therapeutics (ADXN) Switzerland $0.048B 0.00
PolarityTE (PTE) United States $0.048B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
GTx (ONCT) United States $0.044B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.040B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.038B 82.09
Novan (NOVN) United States $0.038B 0.00
IsoRay (ISR) United States $0.038B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.038B 0.00
AgeX Therapeutics (AGE) United States $0.036B 0.00
Mannatechorporated (MTEX) United States $0.035B 6.70
Neos Therapeutics (NEOS) United States $0.034B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.033B 0.00
ElectroCore (ECOR) United States $0.031B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.030B 0.00
Jaguar Animal Health (JAGX) United States $0.029B 0.00
India Globalization Capital (IGC) United States $0.024B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.022B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Flex Pharma (SLRX) United States $0.018B 0.00
Can-Fite Biopharma (CANF) Israel $0.017B 0.00
Iterum Therapeutics (ITRM) Ireland $0.017B 0.00
ProPhase Labs (PRPH) United States $0.017B 0.00
Shineco (TYHT) China $0.015B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Regulus Therapeutics (RGLS) United States $0.014B 0.00
Cyanotech (CYAN) United States $0.014B 33.29
Sonoma Pharmaceuticals (SNOA) United States $0.013B 0.00
RXi Pharmaceuticals (PHIO) United States $0.010B 0.00
Vical (BBI) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00